Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Cash flows used in operating activities:
Net loss	$ (373,910)	$ (3,258,955)
Adjustments to reconcile net loss to net cash (used in) operating activities:
Depreciation and amortization	49,851	103,545
Amortization of right-of-use assets	9,939	13,451
Non-cash interest expense	619
Stock based compensation		426,281
Provision for accounts receivable allowances		(29,741)
Vendor liability forgiveness, net of asset transfers		2,364,954
Changes in operating assets and liabilities:
Accounts receivable		709,383
Inventories		404,299
Prepaid expenses and other current assets	40,408	6,936
Other assets	(87,631)	15,184
Accounts payable	(42,648)	(3,157,987)
Accrued expenses	27,144	(66,164)
Due to related party	5,170
Operating lease liabilities		(13,451)
Net cash used in operating activities	(371,058)	(2,482,265)
Cash flows from investing activities:
Net cash used in investing activities
Cash flows from financing activities:
Proceeds from preferred stock issuance		2,800,000
Proceeds from debt	350,000
Net cash provided by financing activities	350,000	2,800,000
Net increase (decrease) in cash and cash equivalents	(21,058)	317,735
Cash and cash equivalents - Beginning	30,162	709,322
Total cash, cash equivalents and restricted cash	9,104	1,027,057
Cash paid during the period for:
Interest
Income taxes